ALPHAMAB-B News

ALPHAMAB-B: (1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME

Apr 23 19:44

ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - UPDATES ON RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003 FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS FOR PRESENTATION AT 2024 AACR ANNUAL MEETING

Apr 10 06:05

ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 3 16:42

ALPHAMAB-B: (1) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION; AND (2) RENEWAL OF THE MASTER TECHNICAL SERVICE AGREEMENT

Apr 2 20:55

ALPHAMAB-B: CONNECTED TRANSACTION ANNOUNCEMENT - RENEWAL OF THE LEASE AGREEMENT

Mar 28 21:56

ALPHAMAB-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023

Mar 28 21:50

ALPHAMAB-B: DATE OF BOARD MEETING

Mar 18 16:33

ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 5 19:00

ALPHAMAB-B: Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Feb 6 16:47

ALPHAMAB-B: Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Feb 6 16:45

ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 6 16:33

ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - LICENSE AGREEMENT WITH 3D MEDICINES AND GLENMARK FOR KN035

Jan 25 08:05

ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 4 19:00

ALPHAMAB-B: EXTENSION OF WAIVER REGARDING THE QUALIFICATION AND EXPERIENCE OF A JOINT COMPANY SECRETARY

Dec 19, 2023 18:31

ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - A PHASE I/II CLINICAL TRIAL OF JSKN033 FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED OR METASTATIC SOLID TUMORS WAS APPROVED IN AUSTRALIA

Dec 8, 2023 12:05

ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - PRESENTATION OF RESEARCH UPDATES ON KN026 AT THE SABCS 2023

Dec 7, 2023 07:21

ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 5, 2023 21:58

ALPHAMAB-B: Next Day Disclosure Return

Nov 28, 2023 20:34

ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - CLARIFICATION

Nov 24, 2023 20:27

ALPHAMAB-B: INSIDE INFORMATION ANNOUNCEMENT - PRELIMINARY RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003 IN AUSTRALIA FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS

Nov 16, 2023 12:24